The Global Summit on Neurodegenerative Diseases NEURO 2020/2022 will take place in the city of Salamanca from June 21 to 24, 2022, under the presidency of H.M. Queen Sofia. This Summit is held within the framework of the event of exceptional interest, "Neurodegenerative Diseases 2020. International Year of Neuro2020 Research and Innovation". That event aims to promote research into neurodegenerative diseases and raise public awareness of the social consequences of these pathologies.
This meeting is annually celebrated under the denomination of International Congress on Innovation and Research in Neurodegenerative Diseases (CiiiEN) and focuses on major research advances in neurodegenerative disorders, particularly Alzheimer's, Parkinson, ALS, and Huntington's diseases. The Congress has been organized since 2013 by the Queen Sofia Foundation, the Center of Research in Neurological Diseases (CIEN) and the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED). It offers a forum to exchange and discuss a range of areas of interest related to basic, clinical and translational aspects of the research on neurodegenerative diseases. The Summit will focus on scientific research by the CIEN Foundation and CIBERNED. Researchers from several countries will attend this Global Summit. Noteworthy is the participation of 2013 Nobel Prize winner in Medicine, Thomas C. Sudhof (Stanford University, California, USA), among other prestigious researchers.
The University of Salamanca will lend its facilities and services for the proper development of the scientific sessions.The GLOBAL SUMMIT Neuro2020/22 will also collaborate with the City Council of Salamanca, which will provide some resources to the cultural activities associated with the scientific program.
We look forward to welcoming you to Salamanca.
Thomas Sudhof , Stanford University, CA
2013 Nobel Laureate in Physiology or Medicine
"Towards an understanding of Alzheimer’s disease as a synaptic disorder"
Orla Hardiman , Trinity College, Dublin
"The Pathway to Precision Medicine in Amyotrophic Lateral Sclerosis"
Leonard Van den Berg , Universiteit Utrecht
"The road to more effective treatment for amyotrophic lateral sclerosis"
Lu Chen, Stanford University, CA
"Retinoic acid receptor-alpha signaling in neuropathic pain"
Rafael Fernández Chacón , Instituto de Biomedicina de Sevilla-IBIS, CIBERNED
"Homeostatic reprograming of neurons upon presynaptic dysfunction"
Sonia Alonso, Biodonostia Research Institute, CIBERNED
"Intrinsic muscle dysfunction in Amyotrophic Lateral Sclerosis"
Juan Pedro Bolaños, Instituto de Biología Funcional y Genómica. Universidad de Salamanca, CIBERFES
"Metabolic shapes of brain cells and functional consequences"
Oscar Fernández-Capetillo, Centro Nacional de Investigaciones Oncológicas-CNIO
"Mechanisms, mouse models and drug development: A cancer researchers´approach to ALS"
Angeles Almeida, Instituto de Investigación Biomédica de Salamanca-IBSAL
"The p53 Arg72Pro polymorphism determines cognitive decline progression in AD"
José J. Lucas, Centro de Biología Molecular “Severo Ochoa”, CIBERNED
"Altered RNA processing in Huntington’s disease"
Eduardo Tolosa, Hospital Clínic-IDIBAPS, CIBERNED
"Disease modification in early Parkinson disease"
David Sulzer, Columbia University, New York
"Autoimmunity in Parkinson’s Disease"
Werner Poewe, Universität Innsbruk
"Diagnosing Parkinson's Disease- from the street to the Bench"
José López Barneo, Instituto de Biomedicina de Sevilla-IBIS, CIBERNED
"Mitochondrial dysfunction and compartmentalized alterations of nigrostriatal dopaminergic neurons in Parkinson disease"
Marcelo Mendonça, Fundação Champalimaud, Lisboa
"Movement and reward modulation in Substantia Nigra pars compacta dopaminergic neurons"
Jaime Kulisevsky, Institut de Recerca Hospital de la Santa Creu i Sant Pau, CIBERNED
"Treatment of Cognitive and Neuropsychiatric impairment in Parkinson’s disease: An unmet need and a methodological challenge"
Inga Zerr, DZNE, Georg August Universität Göttingen
"Cerebrospinal fluid and blood based biomarker- recent advances in neurodegenerative diseases"
Teresa Iglesias, Instituto de Investigaciones Biomédicas, “Alberto Sols” CSIC-UAM, CIBERNED
"Molecular targets for Ventriculomegaly and Neurodegeneration"
Joe Paton, Champalimaud Foundation, Lisbon
"Action suppression reveals opponent parallel control of behavior via basal ganglia circuits"
Nozha Borjini, Instituto de Biomedicina de Sevilla-IBIS, CIBERNED (poster #2)
"Microglia in the presynaptic dysfunction and neurodegeneration in mice lacking the synaptic co-chaperone CSPα/DNAJC5"
José Jiménez-Villegas, Instituto de Investigaciones Biomédicas "Alberto Sols" CSIC-UAM, CIBERNED (poster #20)
"Redox, mitochondrial and NRF2 imbalance are present in C9orf72-related amyotrophic lateral sclerosis"
Letizia Moreno-García, Universidad de Zaragoza, CIBERNED (poster #10)
"Circular RNAs as blood-based biomarkers of ALS"
José Luis Lanciego, CIMA-Universidad de Navarra, CIBERNED (poster #21)
"Blaming neuromelanin for Parkinson's disease: time-dependent tyrosinase overexpression drives endogenous synucleinopathy in nonhuman primates"
Marta Garo-Pascual, Fundación CIEN (poster #35)
"A hippocampal-anterior thalamic circuit associated with learning rate in ageing"
Iván Burgueño, Fundación CIEN-Fundación ACS (poster #39)
"Neuropathological variability in Alzheimer’s disease. in search of distinct phenotypes of tau pathology"
Montse Solé, Institut de Recerca Vall d’Hebron-UAB, CIBERNED (poster 41)
"FAIM-L as a modulator of Tau pathology in Alzheimer's disease and other tauopathies"
Inmaculada Cuchillo-Ibáñez, Instituto de Neurociencias, UMH-CSIC, CBERNED (poster #60)
"CSF Apolipoprotein E characterization in Alzheimer’s disease"
Michel Goedert, MRC Laboratory of Molecular Biology, Cambridge
"Cryo-EM structures of amyloid filaments from human brain"
Kenneth S. Kosik, University of California at Santa Barbara
"A Tangle of Tau Pathways Operate within Cellular Systems"
Luc Buée, Inserm, CHR, Université de Lille
"Tau therapeutic strategies"
George Perry, University of Texas at San Antonio
"In search of a cure for Alzheimer disease"
Marta Pascual, Universitat de Barcelona, CIBERNED
"J20/VLW mice as a novel model of cognitive resilience to Alzheimer’s disease"
Bryan Strange, Fundación CIEN
"Superaging in Vallecas: Resistance to age-related memory decline"
Bruce Miller, University of California at San Francisco
"Frontotemporal Dementia: Diagnosis to Treatment"
Raquel Sánchez-Valle, Hospital Clinic de Barcelona, IDIBAPS
"Autosomal dominantly inherited dementias: from genetic counselling to early intervention"
Juan Domingo Gispert López, Barcelonabeta Brain Research Center (BBRC)
"Early pathophysiological alterations in Alzheimer's disease: insights from the ALFA cohort"
Julia Terreros Roncal, Young Investigator Award Centro de Biología Molecular "Severo Ochoa" CSIC-UAM, CIBERNED
"Impact of neurodegenerative diseases on human adult hippocampal neurogenesis"
Alberto Rábano, Fundación CIEN
"Clinicopathological heterogeneity in Alzheimer’s disease: lessons from the Vallecas Alzheimer’s Study"
Pascual Sánchez-Juan, Fundación CIEN, CIBERNED
"Plasma biomarkers in the Vallecas study. Bridging the gap on the road to the clinic"
Isabel Fariñas, Universitat de València, CIBERNED
"Immune vigilance of adult neural stem cells"
Angel Cedazo-Mínguez, Karolinska Institute
"Danger-associated responses in Alzheimer’s disease brain: Alarmins and Chaperons"
María Llorens-Martín, Centro de Biología Molecular “Severo Ochoa”- CSIC-UAM, CIBERNED
"Adult hippocampal neurogenesis and neurodegenerative diseases"
The form has been sent successfully.